Metraipolis › archive › dc_382f6bfa9282

Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine — Europe PMC PMID:39771605

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39771605
DOI
10.3390/pharmaceutics16121627
License (as archived)
solo-consultazione
Archived
2026-10-07T19:25:25.335Z
SHA-256 of the archived text
efd11abc98f5e2097c305ecaa8859e9efbf992aa37d5382cca31a732fa8827d5
Stable URL of this page
https://metraipolis.com/documento/dc_382f6bfa9282

How to cite

Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine — Europe PMC PMID:39771605 — Europe PMC (en), https://europepmc.org/article/MED/39771605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_382f6bfa9282 (Metraipolis archive dc_382f6bfa9282, sha256 efd11abc98f5e2097c305ecaa8859e9efbf992aa37d5382cca31a732fa8827d5)
BibTeX
@misc{dc382f6bfa9282,
  title = {Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine — Europe PMC PMID:39771605},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39771605},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_382f6bfa9282; sha256 efd11abc98f5e2097c305ecaa8859e9efbf992aa37d5382cca31a732fa8827d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39771605. Agents can read the archived copy with the MCP tool read_document.